Oklahoma House Bill HB1161

Oklahoma 2026 Regular Session

• Introduced: 2/3/25
• Refer: 2/4/25
• Report Pass: 3/3/25
• Engrossed: 2/10/26
• Refer: 4/1/26

Caption

Insurance; health benefit plans; insurance committees; impact analysis; Legislative Service Bureau; Oklahoma Insurance Department; report; effective date.

Summary

HB1161 creates a new process for evaluating proposed legislation that would impose mandates on health benefit plans. It defines key terms such as “bureau,” “department,” “health benefit plan,” and “mandate,” with mandates including requirements that expand coverage or impose operational or administrative obligations on insurers. Under the bill, when the Speaker of the House or the President Pro Tempore of the Senate determines a bill contains such a mandate, they may direct the Legislative Service Bureau to refer the bill to the Oklahoma Insurance Department for an impact analysis. The Insurance Department must return a written report within 60 days. That report must address the mandate’s social impact, medical efficacy, and financial impact, including effects on premiums, insurers, providers, state-funded programs, and the stability of the insurance market. The Department may use third-party actuarial or insurance-mandate experts and may seek input from other state agencies. The bill also limits referrals to six per fiscal year unless the Insurance Commissioner approves additional referrals in writing, and requires the resulting report to be shared with the bill author, committee chair, and posted publicly online.

Impact

If enacted, HB1161 would add a formal review layer to the legislative process for bills affecting health insurance coverage and insurer operations, but it would not itself mandate coverage or change substantive insurance benefits. It would place the Oklahoma Insurance Department in an advisory role for selected bills, create a statutory reporting requirement, and establish limits and procedures for referrals from the Legislative Service Bureau. The bill would be codified in Title 36 and take effect November 1, 2026, thereby affecting how future health-benefit-plan mandates are analyzed before enactment.

Sentiment

The available voting history suggests the bill has generally received support, advancing through committee and passing the House on third reading by a clear margin. The transcript from final House passage indicates no debate at that stage, which suggests limited visible opposition on the floor. However, the earlier committee votes show some resistance, indicating that while the bill was broadly acceptable to many members, it was not unanimous and drew some skepticism during committee consideration.

Contention

The main points of contention appear to be the bill’s gatekeeping and workload implications. Supporters likely view the measure as a way to improve legislative decision-making by requiring evidence-based review of insurance mandates, including cost and medical-effectiveness analysis. Critics may be concerned that the referral process gives legislative leaders discretion over which bills are analyzed, that the six-referral cap could limit review, or that the process could slow consideration of health-related legislation. There may also be concern about the burden on the Insurance Department and the use of third-party vendors, especially if the analysis is seen as influencing policy outcomes rather than simply informing them.